Interleukin‐19 ameliorates experimental autoimmune encephalitis
Interleukin‐19 ameliorates experimental autoimmune encephalitis
复制标题
Interleukin-19 可改善实验性自身免疫性脑炎
DOI:
10.1111/cen3.12642
复制
发表时间:
2021
影响因子:
--
通讯作者:
Suzumura Akio
中科院分区:
文献类型:
--
作者:
Takeuchi Hideyuki;Horiuchi Hiroshi;Parajuli Bijay;Komiya Hiroyasu;Tanaka Fumiaki;Suzumura Akio
Interleukin-19 suppresses microglia/macrophage antigen presentation, T helper 17 cell expansion and subsequent inflammation in the central nervous system, resulting in improvement in experimental autoimmune encephalomyelitis. Keywords: antigen presentation; macrophage; microglia; multiple sclerosis; T helper 17 cell EN antigen presentation macrophage microglia multiple sclerosis T helper 17 cell 148 149 2 09/02/21 20210801 NES 210801 Interleukin-19 serves as a negative feedback regulator to limit the pro-inflammatory response of macrophages and microglia in autocrine/paracrine manners. These data showed that IL-19 plays a pivotal role in the suppression of MS pathogenesis by inhibiting microglia/macrophage antigen presentation, Th17 cell expansion and subsequent inflammation in the CNS.[Extracted from the article]Copyright of Clinical & Experimental Neuroimmunology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. Copyright applies to all Abstracts.